MedTrace Logo

Optimizing Diagnostics Of Syncope Events Using Intelligent Telemetric Solutions.

NCT01265290 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 640

Last updated 2011-12-05

No results posted yet for this study

Summary

The purpose of this study is to assess efficacy of prolonged Full Disclosure electrocardiogram (ECG) monitoring and signal analysis using advanced telemetric technology to diagnose syncope in comparison with standard diagnostic procedure

Conditions

  • Cardiac Arrhythmia
  • Cardiogenic Syncope

Interventions

DEVICE

repeated 24 hours ECG Holter monitoring

repeated 24 hours ECG Holter monitoring

DEVICE

Telemetric ECG monitoring

Telemetric ECG full disclosure monitoring with GSM technology

Sponsors & Collaborators

  • National Institute of Cardiology, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Lukasz Szumowski, Prof. MD PhD · National Institute of Cardiology, Warsaw, Poland

  • Katarzyna Bieganowska, Prof. MD PhD · Children's Memorial Health Institute

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-12-31
Completion
2013-01-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01265290 on ClinicalTrials.gov